Ambulatory Blood Pressure Reduction After Rosiglitazone Treatment In Normotensive Type 2 Diabetic Patients
Status:
Completed
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to determine the effects of rosiglitazone in normotensive type
2 diabetic patients with regard to its blood-pressure-reducing effects.